Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Shortness: an unknown phenotype of multiple endocrine neoplasia type 1.

López CL, Langer P, Waldmann J, Fendrich V, Sitter H, Nies C, Bartsch DK.

Eur J Endocrinol. 2013 Jul;169(1):133-7.

2.

The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1.

Lourenço DM Jr, Toledo RA, Coutinho FL, Margarido LC, Siqueira SA, dos Santos MA, Montenegro FL, Machado MC, Toledo SP.

Clinics (Sao Paulo). 2007 Aug;62(4):465-76.

3.

Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.

Longuini VC, Lourenço DM Jr, Sekiya T, Meirelles O, Goncalves TD, Coutinho FL, Francisco G, Osaki LH, Chammas R, Alves VA, Siqueira SA, Schlesinger D, Naslavsky MS, Zatz M, Duarte YA, Lebrão ML, Gama P, Lee M, Molatore S, Pereira MA, Jallad RS, Bronstein MD, Cunha-Neto MB, Liberman B, Fragoso MC, Toledo SP, Pellegata NS, Toledo RA.

Eur J Endocrinol. 2014 Sep;171(3):335-42. doi: 10.1530/EJE-14-0130.

4.

Multiple endocrine neoplasia type 1 (MEN1) in Austria.

Weinhäusel A, Kaserer K, Vierhapper H, Niederle B, Haas OA; Study Group of Multiple Endocrine Neoplasia Austria..

Wien Klin Wochenschr. 2002 Apr 15;114(7):252-7.

PMID:
12089860
5.

Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).

Lairmore TC, Piersall LD, DeBenedetti MK, Dilley WG, Mutch MG, Whelan AJ, Zehnbauer B.

Ann Surg. 2004 May;239(5):637-45; discussion 645-7.

6.

Novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.

Jap TS, Chiu CY, Won JG, Wu YC, Chen HS.

Clin Endocrinol (Oxf). 2005 Mar;62(3):336-42.

PMID:
15730416
7.

Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.

Machens A, Schaaf L, Karges W, Frank-Raue K, Bartsch DK, Rothmund M, Schneyer U, Goretzki P, Raue F, Dralle H.

Clin Endocrinol (Oxf). 2007 Oct;67(4):613-22.

PMID:
17590169
8.

Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.

van Leeuwaarde RS, van Nesselrooij BP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, de Laat JM, Pieterman CR, Valk GD.

J Clin Endocrinol Metab. 2016 Mar;101(3):1159-65. doi: 10.1210/jc.2015-3766.

PMID:
26751192
9.

Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N, Waterlot C, Bauters C, Porchet N, Aubert JP, Emy P, Cadiot G, Delemer B, Chabre O, Niccoli P, Leprat F, Duron F, Emperauger B, Cougard P, Goudet P, Sarfati E, Riou JP, Guichard S, Rodier M, Meyrier A, Caron P, Vantyghem MC, Assayag M, Peix JL, Pugeat M, Rohmer V, Vallotton M, Lenoir G, Gaudray P, Proye C, Conte-Devolx B, Chanson P, Shugart YY, Goldgar D, Murat A, Calender A.

Am J Hum Genet. 1998 Aug;63(2):455-67.

10.

[Multiple endocrine neoplasia type 1 variants and phenocopies].

Mamedova EO, Mokrysheva NG, Przhiialkovskaia EG, Pigarova EA, Rozhinskaia LIa, Tiul'pakov AN.

Ter Arkh. 2014;86(10):87-91. Review. Russian.

PMID:
25509899
11.

Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.

Lourenço DM Jr, Toledo RA, Mackowiak II, Coutinho FL, Cavalcanti MG, Correia-Deur JE, Montenegro F, Siqueira SA, Margarido LC, Machado MC, Toledo SP.

Eur J Endocrinol. 2008 Sep;159(3):259-74. doi: 10.1530/EJE-08-0153.

12.

MEN1 c.825‑1G>A mutation in a family with multiple endocrine neoplasia type 1: A case report.

Ning Z, Wang O, Meng X, Xing X, Xia W, Jiang Y, Li M, Xu Y.

Mol Med Rep. 2015 Oct;12(4):6152-6. doi: 10.3892/mmr.2015.4138.

PMID:
26239674
13.

Type 1 multiple endocrine neoplasia (MEN1): contribution of genetic analysis to the screening and follow-up of a large French kindred.

Waterlot C, Porchet N, Bauters C, Decoulx M, Wémeau JL, Proye C, Degand PM, Aubert JP, Cortet C, Dewailly D.

Clin Endocrinol (Oxf). 1999 Jul;51(1):101-7.

PMID:
10468972
14.

Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1.

Toledo RA, Lourenço DM Jr, Coutinho FL, Quedas E, Mackowiack I, Machado MC, Montenegro F, Cunha-Neto MB, Liberman B, Pereira MA, Correa PH, Toledo SP.

Clin Endocrinol (Oxf). 2007 Sep;67(3):377-84.

PMID:
17555499
15.

Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.

Vierimaa O, Ebeling TM, Kytölä S, Bloigu R, Eloranta E, Salmi J, Korpi-Hyövälti E, Niskanen L, Orvola A, Elovaara E, Gynther A, Sane T, Välimäki M, Ignatius J, Leisti J, Salmela PI.

Eur J Endocrinol. 2007 Sep;157(3):285-94.

16.

Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).

Turner JJ, Christie PT, Pearce SH, Turnpenny PD, Thakker RV.

Hum Mutat. 2010 Jan;31(1):E1089-101. doi: 10.1002/humu.21170.

PMID:
19953642
17.

Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene.

Balogh K, Patócs A, Majnik J, Varga F, Illyés G, Hunyady L, Rácz K.

J Hum Genet. 2004;49(7):380-6.

PMID:
15205994
18.
19.

Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.

Gonçalves TD, Toledo RA, Sekiya T, Matuguma SE, Maluf Filho F, Rocha MS, Siqueira SA, Glezer A, Bronstein MD, Pereira MA, Jureidini R, Bacchella T, Machado MC, Toledo SP, Lourenço DM Jr.

J Clin Endocrinol Metab. 2014 Jan;99(1):E89-96. doi: 10.1210/jc.2013-1768.

PMID:
24178797
20.

Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.

Sakurai A, Katai M, Yumita W, Minemura K, Hashizume K.

Endocrine. 2004 Feb;23(1):45-9.

PMID:
15034196
Items per page

Supplemental Content

Support Center